Calendar Companies Compare Analytics Learn Watchlist

Search CatalystAlert

Search for companies, drugs, and catalysts

Loading market movers...

Free biotech catalyst calendar tracking FDA decisions, clinical trial results, and PDUFA dates for biotech stocks.

Quick Links

Catalyst Calendar
Search Companies
Biotech Glossary
Therapeutic Areas

Legal

About
Privacy
Terms

Data Sources

ClinicalTrials.gov
SEC EDGAR
FDA

© 2025 CatalystAlert. All rights reserved.

Not financial advice. Data may be delayed or incomplete.

Navepegritide - Phase 2 | ASND Pipeline | CatalystAlert

Navepegritide

Phase 2

Ascendis Pharma A/S (ASND)

16%

Phase 2

Development Phase

1

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts

Mar 2026~

ASNDPhase 2Phase 2

Navepegritide Phase 2 Results Expected

Navepegritide • Achondroplasia

Drug Information

Target Indication

Achondroplasia

Clinical Trial

Last updated: 12/4/2025

Developer

ASND

Ascendis Pharma A/S

Biotechnology•Europe•NASDAQ